ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,112,000 | -6.1% | 820,320 | 0.0% | 18.96% | -7.6% |
| Q2 2022 | $28,883,000 | -23.4% | 820,320 | +0.0% | 20.53% | -6.3% |
| Q1 2022 | $37,726,000 | -30.6% | 820,316 | +0.0% | 21.90% | -23.3% |
| Q4 2021 | $54,386,000 | +6.2% | 820,303 | -0.0% | 28.54% | -6.0% |
| Q3 2021 | $51,213,000 | -24.6% | 820,328 | +0.0% | 30.37% | -17.3% |
| Q2 2021 | $67,934,000 | +24.9% | 820,264 | 0.0% | 36.71% | +10.5% |
| Q1 2021 | $54,392,000 | -13.6% | 820,264 | -0.0% | 33.22% | -19.7% |
| Q4 2020 | $62,945,000 | – | 820,346 | – | 41.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |